Stockreport

How The Narrative Around Nektar Therapeutics (NKTR) Is Shifting With Rezpeg Data And Litigation Risks [Yahoo! Finance]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF revenue growth assumption for Rezpeg edged to a 10.83% decline. This reflects a slightly less negative view of future sales potential tied to upcoming clinical data and [Read more]